{"altmetric_id":4692600,"citation":{"altmetric_jid":"clinicaltrialsgov","authors":["Biota Scientific Management Pty Ltd","Aviragen Therapeutics ( Biota Scientific Management Pty Ltd )"],"first_seen_on":"2015-10-28T14:55:38+00:00","issns":[],"journal":"ClinicalTrials.gov","last_mentioned_on":1470029937,"links":["http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01793883?rank=1&term=IGLOO+Trial","https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT01793883"],"nct_id":"NCT01793883","pubdate":"2013-02-13T00:00:00+00:00","publisher":"ClinicalTrials.gov","title":"Efficacy and Safety Study of Laninamivir Octanoate TwinCaps\u00ae Dry Powder Inhaler in Adults With Influenza (Igloo)","type":"clinical_trial_study_record"},"altmetric_score":{"score":1,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1},"context_for_score":{"all":{"total_number_of_other_articles":8150076,"mean":6.9043957460448,"rank":4317518,"this_scored_higher_than_pct":27,"this_scored_higher_than":2262435,"rank_type":"exact","sample_size":8150076,"percentile":27},"similar_age_3m":{"total_number_of_other_articles":243477,"mean":9.7892065994183,"rank":127068,"this_scored_higher_than_pct":37,"this_scored_higher_than":91226,"rank_type":"exact","sample_size":243477,"percentile":37},"this_journal":{"total_number_of_other_articles":23297,"mean":10.497456473214,"rank":13420,"this_scored_higher_than_pct":32,"this_scored_higher_than":7657,"rank_type":"exact","sample_size":23297,"percentile":32},"similar_age_this_journal_3m":{"total_number_of_other_articles":1087,"mean":14.369342541436,"rank":611,"this_scored_higher_than_pct":33,"this_scored_higher_than":362,"rank_type":"exact","sample_size":1087,"percentile":33}}},"demographics":{"poster_types":{"member_of_the_public":2},"users":{"twitter":{"cohorts":{"Members of the public":2}}}},"counts":{"total":{"posts_count":2},"twitter":{"unique_users_count":2,"unique_users":["kojima_aponet","nrmkx"],"posts_count":2}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/kojima_aponet\/status\/495192562177556481","license":"datasift","citation_ids":[4692600],"posted_on":"2014-08-01T13:01:21+00:00","author":{"name":"\u5c0f\u5d8b \u614e\u4e8c\uff20\u30a2\u30dd\u30cd\u30c3\u30c8","url":"http:\/\/www.watarase.ne.jp\/aponet\/blog\/","image":"https:\/\/pbs.twimg.com\/profile_images\/1864221167\/aponet_profile_normal.jpg","description":"\u6803\u6728\u770c\u8db3\u5229\u5e02\u306e\u5730\u57df\u85ac\u5c40\u306e\u85ac\u5264\u5e2b\u3067\u3059\u3002\u81ea\u4e3b\u7684\u52c9\u5f37\u4f1a\u306e\u30a2\u30dd\u30cd\u30c3\u30c8R\u7814\u7a76\u4f1a\u306e\u4e16\u8a71\u4eba\u3092\u3057\u3066\u3044\u307e\u3059\u3002\u304f\u3059\u308a\u3084\u533b\u7642\u30fb\u5065\u5eb7\u554f\u984c\u3001\u6d77\u5916\u306e\u85ac\u5264\u5e2b\u6d3b\u52d5\u306b\u3064\u3044\u3066\u3064\u3076\u3084\u304d\u307e\u3059\u3002","id_on_source":"kojima_aponet","tweeter_id":"508573844","geo":{"lt":null,"ln":null},"followers":2082},"tweet_id":"495192562177556481"},{"url":"http:\/\/twitter.com\/nrmkx\/statuses\/759986756938665984","license":"gnip","citation_ids":[4692600],"posted_on":"2016-08-01T05:38:57+00:00","author":{"name":"\u306e\u308a\u307e\u304d","image":"https:\/\/pbs.twimg.com\/profile_images\/518901068596404224\/G3sYuOdk_normal.png","description":"DI\u3068\u611f\u67d3\u3084\u3063\u3066\u308b\u75c5\u9662\u306e\u3084\u304f\u3056\u3044\u3057","id_on_source":"nrmkx","tweeter_id":"146812018","geo":{"lt":null,"ln":null},"followers":655},"tweet_id":"759986756938665984"}]}}